118 related articles for article (PubMed ID: 29366963)
21. Purification, visualization, and biophysical characterization of Kv1.3 tetramers.
Spencer RH; Sokolov Y; Li H; Takenaka B; Milici AJ; Aiyar J; Nguyen A; Park H; Jap BK; Hall JE; Gutman GA; Chandy KG
J Biol Chem; 1997 Jan; 272(4):2389-95. PubMed ID: 8999950
[TBL] [Abstract][Full Text] [Related]
22. Immunosuppressive evidence of Tityus serrulatus toxins Ts6 and Ts15: insights of a novel K(+) channel pattern in T cells.
Pucca MB; Bertolini TB; Cerni FA; Bordon KC; Peigneur S; Tytgat J; Bonato VL; Arantes EC
Immunology; 2016 Feb; 147(2):240-50. PubMed ID: 26595158
[TBL] [Abstract][Full Text] [Related]
23. Functional role of Kv1.1 and Kv1.3 channels in the neoplastic progression steps of three cancer cell lines, elucidated by scorpion peptides.
Aissaoui D; Mlayah-Bellalouna S; Jebali J; Abdelkafi-Koubaa Z; Souid S; Moslah W; Othman H; Luis J; ElAyeb M; Marrakchi N; Essafi-Benkhadir K; Srairi-Abid N
Int J Biol Macromol; 2018 May; 111():1146-1155. PubMed ID: 29415410
[TBL] [Abstract][Full Text] [Related]
24. Margatoxin is a non-selective inhibitor of human Kv1.3 K+ channels.
Bartok A; Toth A; Somodi S; Szanto TG; Hajdu P; Panyi G; Varga Z
Toxicon; 2014 Sep; 87():6-16. PubMed ID: 24878374
[TBL] [Abstract][Full Text] [Related]
25. Expression and characterization of a novel scorpine-like peptide Ev37, from the scorpion Euscorpiops validus.
Feng J; Yu C; Wang M; Li Z; Wu Y; Cao Z; Li W; He X; Han S
Protein Expr Purif; 2013 Mar; 88(1):127-33. PubMed ID: 23262394
[TBL] [Abstract][Full Text] [Related]
26. Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo.
Jang SH; Choi SY; Ryu PD; Lee SY
Eur J Pharmacol; 2011 Jan; 651(1-3):26-32. PubMed ID: 21087602
[TBL] [Abstract][Full Text] [Related]
27. Fluorescent system based on bacterial expression of hybrid KcsA channels designed for Kv1.3 ligand screening and study.
Kudryashova KS; Nekrasova OV; Kuzmenkov AI; Vassilevski AA; Ignatova AA; Korolkova YV; Grishin EV; Kirpichnikov MP; Feofanov AV
Anal Bioanal Chem; 2013 Mar; 405(7):2379-89. PubMed ID: 23307127
[TBL] [Abstract][Full Text] [Related]
28. Toxin-induced conformational changes in a potassium channel revealed by solid-state NMR.
Lange A; Giller K; Hornig S; Martin-Eauclaire MF; Pongs O; Becker S; Baldus M
Nature; 2006 Apr; 440(7086):959-62. PubMed ID: 16612389
[TBL] [Abstract][Full Text] [Related]
29. Tityustoxin-K(alpha) blockade of the voltage-gated potassium channel Kv1.3.
Rodrigues AR; Arantes EC; Monje F; Stühmer W; Varanda WA
Br J Pharmacol; 2003 Jul; 139(6):1180-6. PubMed ID: 12871837
[TBL] [Abstract][Full Text] [Related]
30. Identification of novel Kv1.3 blockers using a fluorescent cell-based ion channel assay.
Slack M; Kirchhoff C; Moller C; Winkler D; Netzer R
J Biomol Screen; 2006 Feb; 11(1):57-64. PubMed ID: 16314404
[TBL] [Abstract][Full Text] [Related]
31. A potent potassium channel blocker from Mesobuthus eupeus scorpion venom.
Gao B; Peigneur S; Tytgat J; Zhu S
Biochimie; 2010 Dec; 92(12):1847-53. PubMed ID: 20713119
[TBL] [Abstract][Full Text] [Related]
32. Selective blockage of Kv1.3 and Kv3.1 channels increases neural progenitor cell proliferation.
Liebau S; Pröpper C; Böckers T; Lehmann-Horn F; Storch A; Grissmer S; Wittekindt OH
J Neurochem; 2006 Oct; 99(2):426-37. PubMed ID: 17029597
[TBL] [Abstract][Full Text] [Related]
33. Engineering a potent and specific blocker of voltage-gated potassium channel Kv1.3, a target for autoimmune diseases.
Chen R; Chung SH
Biochemistry; 2012 Mar; 51(9):1976-82. PubMed ID: 22352687
[TBL] [Abstract][Full Text] [Related]
34. The Scorpion Toxin Analogue BmKTX-D33H as a Potential Kv1.3 Channel-Selective Immunomodulator for Autoimmune Diseases.
Ye F; Hu Y; Yu W; Xie Z; Hu J; Cao Z; Li W; Wu Y
Toxins (Basel); 2016 Apr; 8(4):115. PubMed ID: 27104568
[TBL] [Abstract][Full Text] [Related]
35. OdK2, a Kv1.3 channel-selective toxin from the venom of the Iranian scorpion Odonthobuthus doriae.
Abdel-Mottaleb Y; Vandendriessche T; Clynen E; Landuyt B; Jalali A; Vatanpour H; Schoofs L; Tytgat J
Toxicon; 2008 Jun; 51(8):1424-30. PubMed ID: 18471844
[TBL] [Abstract][Full Text] [Related]
36. C-Terminal residues in small potassium channel blockers OdK1 and OSK3 from scorpion venom fine-tune the selectivity.
Kuzmenkov AI; Peigneur S; Chugunov AO; Tabakmakher VM; Efremov RG; Tytgat J; Grishin EV; Vassilevski AA
Biochim Biophys Acta Proteins Proteom; 2017 May; 1865(5):465-472. PubMed ID: 28179135
[TBL] [Abstract][Full Text] [Related]
37. The effects of Kv1.3 and IKCa1 potassium channel inhibition on calcium influx of human peripheral T lymphocytes in rheumatoid arthritis.
Toldi G; Bajnok A; Dobi D; Kaposi A; Kovács L; Vásárhelyi B; Balog A
Immunobiology; 2013 Mar; 218(3):311-6. PubMed ID: 22705192
[TBL] [Abstract][Full Text] [Related]
38. Predominant expression of Kv1.3 voltage-gated K+ channel subunit in rat prostate cancer cell lines: electrophysiological, pharmacological and molecular characterisation.
Fraser SP; Grimes JA; Diss JK; Stewart D; Dolly JO; Djamgoz MB
Pflugers Arch; 2003 Aug; 446(5):559-71. PubMed ID: 12838421
[TBL] [Abstract][Full Text] [Related]
39. GFP-Margatoxin, a Genetically Encoded Fluorescent Ligand to Probe Affinity of Kv1.3 Channel Blockers.
Denisova KR; Orlov NA; Yakimov SA; Kryukova EA; Dolgikh DA; Kirpichnikov MP; Feofanov AV; Nekrasova OV
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163644
[TBL] [Abstract][Full Text] [Related]
40. A three-residue, continuous binding epitope peptidomimetic of ShK toxin as a Kv1.3 inhibitor.
Harvey AJ; Gable RW; Baell JB
Bioorg Med Chem Lett; 2005 Jul; 15(13):3193-6. PubMed ID: 15935664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
